• Sections
  • Newsletters
  • Podcasts
  • Support TPM
  • Shop Merch
  • Site Info
  • About
  • Sections
  • Editors' Blog
  • News
  • Live Blog
  • Cafe
  • Muckraker
  • Morning Memo
  • Where Things Stand
  • The Weekender
  • The Franchise
  • Features
  • Support TPM
  • Memberships
  • The TPM Journalism Fund
  • Site Info
  • FAQ
  • Contact
  • Advertise
  • Terms
  • Privacy
  • Site Status
  • About
  • About TPM
  • Mission
  • Masthead
  • Financials
  • Careers
  • Pitch Us
Follow TPM
© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.
Talking Points Memo Logo
Send Tips TPM 25th Anniversary Badge
COVID-19
Trump Says He Plans On Holding Rally On Saturday, Won’t Say If He’s Tested Negative
By Cristina Cabrera
10.09.20 | 7:50 am
HHS Whistleblower Takes Aim At Trump’s ‘Reckless’ Pre-Election COVID Vaccine Push
By Summer Concepcion
10.08.20 | 6:55 pm
TARRYTOWN, NEW YORK, UNITED STATES - 2020/10/02: View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals, Inc. on Old Saw Mill River Road. As President Donald Trump contracted COVID-19 he has been administered a dose of experimental Regeneron treatment, according to a memorandum from the President's physician. According to company press release antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19. (Photo by Lev Radin/Pacific Press/LightRocket via Getty Images) TARRYTOWN, NEW YORK, UNITED STATES - 2020/10/02: View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals, Inc. on Old Saw Mill River Road. As President Donald Trump contracted COVID-19 he has been administered a dose of experimental Regeneron treatment, according to a memorandum from the President's physician. According to company press release antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19. (Photo by Lev Radin/Pacific Press/LightRocket via Getty Images)
President Plays Pitchman For Another Experimental COVID ‘Cure’ Prime Badge
This Week in the Swamp: A weekly dive into the muck of the Trump administration.
By Matt Shuham
10.08.20 | 6:07 pm
Court Blocks Extended Deadline For WI Ballots As State Explodes With COVID Cases
By Kate Riga
10.08.20 | 4:01 pm
Where Things Stand: Different Standards Are McConnell’s Favorite Cop-Out Prime Badge
This is your TPM afternoon briefing.
By Nicole LaFond
10.08.20 | 1:50 pm

The Senate majority leader’s hazy statements distancing himself from the administration’s missteps are a staple of his leadership in the Trump era.

Read More

Donald ‘Law And Order’ Trump Keeps Blaming Cops And Soldiers For Giving Him COVID
By Kate Riga
10.08.20 | 12:57 pm
Trump Describes Himself As A ‘Perfect Physical Specimen’ Amid COVID Recovery
By Zoe Richards
10.08.20 | 9:58 am
Report: Trump Plans To Hit The Campaign Trail Again As Soon As Monday
By Cristina Cabrera
10.08.20 | 9:23 am
Trump Required NDAs From Walter Reed Doctors During Surprise Medical Visit Last Year
By Zoe Richards
10.08.20 | 7:55 am
Trump Bails On Next Debate After Commission Announces Virtual Format
By Cristina Cabrera
10.08.20 | 7:49 am
Next →
Talking Points Memo
© 2026 TPM MEDIA LLC.
Masthead Contact Privacy Policy
  • About
  • Memberships
  • Careers
  • Advertise
  • Site Status
  • FAQ
  • Newsletters
  • Pitch Us
  • Terms of Use
  • CCPA Notice